Exploring the Antitubercular, Antimicrobial Potency, ADME‐T Calculations and Docking Studies of 1,2,4‐Triazole‐Bearing Benzimidazoles
Chemistry & Biodiversity · 2026
DOI: 10.1002/cbdv.71539 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Khaja Mohiddin Shaik und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, School of Applied Sciences, REVA University, Bengaluru, Karnataka, India. Hauptthemen laut MEDLINE: Triazoles, Molecular Docking Simulation, Benzimidazoles, Antitubercular Agents. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
We report the synthesis and assessment of novel benzimidazole–triazole scaffolds ( 4a–4j ) as antimicrobial/antitubercular medicines. Two‐pot condensation processes were used to synthesize the target compounds. Spectroscopic techniques such as mass spectrometry and nuclear magnetic resonance ( 1 H/ 13 C) spectroscopy were used to characterize the synthesized molecules. The remarkable in vitro activity of compounds 4d and 4h (MICs 2.65 ± 1.10 and 2.57 ± 0.34 µM) is comparable activity to conventional drug Streptomycin (MIC = 2.90 ± 0.47 µM), indicates that these are promising new class of anti‐tubercular medicines. Among the tested molecules, 4h and 4i exhibited exceptional antibacterial activity with minimum inhibitory concentrations of 3.15 ± 0.23 and 4.81 ± 0.18 µM against the Bacillus cereus , when compared to Moxifloxacin (MIC = 3.52±0.60 µM). Antifungal profiles showed that compounds 4d and 4i had better antifungal inhibitory potency against Fusarium oxysporum with MIC values of 4.91 ± 1.51 and 3.68 ± 0.12 µM, respectively. Solid binding affinities (−6.85 to −9.26 kcal/mol) with the Mycobacterium TB DprE1 (PDB code: 4FDN) and methicillin‐resistant Staphylococcus aureus (PDB ID: 1MWR) through important active sites of H−bond and hydrophobic interaction residues are shown by the in silico molecular docking studies, which offer solid support for their mode of action.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, School of Applied Sciences, REVA University, Bengaluru, Karnataka, India.
- Department of Chemistry, Geethanjali College of Engineering and Technology, Medchal, Telangana, India.
- Department of Zoology, Dr. B. R. Ambedkar Open University, Hyderabad, Telangana, India.
- Research Institute, Dong-A ST Co., Ltd, Yongin, South Korea.
ORCID-Profile: Khaja Mohiddin Shaik, Srinu Bhoomandla, Kishore Mendam, Punna Reddy Ullapu
Zitieren
APA
Shaik, K. M., Pandurangan, K., Bhoomandla, S., Mendam, K., & Ullapu, P. R. (2026). Exploring the Antitubercular, Antimicrobial Potency, ADME‐T Calculations and Docking Studies of 1,2,4‐Triazole‐Bearing Benzimidazoles. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.71539
Vancouver
Shaik KM, Pandurangan K, Bhoomandla S, Mendam K, Ullapu PR. Exploring the Antitubercular, Antimicrobial Potency, ADME‐T Calculations and Docking Studies of 1,2,4‐Triazole‐Bearing Benzimidazoles. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.71539
BibTeX
@article{Shaik2026,
author = {Shaik, Khaja Mohiddin and Pandurangan, Komala and Bhoomandla, Srinu and Mendam, Kishore and Ullapu, Punna Reddy},
title = {Exploring the Antitubercular, Antimicrobial Potency, ADME‐T Calculations and Docking Studies of 1,2,4‐Triazole‐Bearing Benzimidazoles},
journal = {Chemistry & Biodiversity},
year = {2026},
doi = {10.1002/cbdv.71539}
}
EUVIMED